排序方式: 共有2条查询结果,搜索用时 0 毫秒
1
1.
Meegdes Marissa Ibragimova Khava I. E. Lobbezoo Dorien J. A. Vriens Ingeborg J. H. Kooreman Loes F. S. Erdkamp Frans L. G. Dercksen M. Wouter Vriens Birgit E. P. J. Aaldering Kirsten N. A. Pepels Manon J. A. E. van de Winkel Linda M. H. Tol Jolien Heijns Joan B. van de Wouw Agnes J. Peters Natascha A. J. B. Hochstenbach-Waelen Ananda Smidt Marjolein L. Geurts Sandra M. E. Tjan-Heijnen Vivianne C. G. 《Breast cancer research and treatment》2022,192(2):331-342
Breast Cancer Research and Treatment - The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer,... 相似文献
2.
Heijns JB van der Burg ME van Gelder T Fieren MW de Bruijn P van der Gaast A Loos WJ 《Cancer chemotherapy and pharmacology》2008,62(5):841-847
PURPOSE: Administration of chemotherapy in patients with renal failure, treated with hemodialysis or continuous ambulatory peritoneal dialysis (CAPD) is still a challenge and literature data is scarce. Here we present a case study of a patient on CAPD, treated with weekly and three-weekly paclitaxel/carboplatin for recurrent ovarian cancer. EXPERIMENTAL: During the first, second and ninth cycle of treatment, blood, urine and CAPD samples were collected for pharmacokinetic analysis of paclitaxel and total and unbound carboplatin-derived platinum. RESULTS: Treatment was well tolerated by the patient. No excessive toxicity was observed and at the end of treatment she was in a complete remission. The plasma pharmacokinetics of paclitaxel were unaltered compared to historical data, with neglectable urinary and CAPD clearance. In contrast, the pharmacokinetics of carboplatin were altered, with doubled half-lives compared to patients with normal renal function. Of the administered carboplatin dose, up to 20% was cleared via the dialysate, while only up to 8% was cleared via the urine. CONCLUSION: Paclitaxel and carboplatin can be safely administered to patients with chronic renal failure on CAPD. For paclitaxel the generally applied dose can be administered, and although for carboplatin dose-adjustment is required due to the diminished renal function, the dose can be calculated using Calvert's formula. 相似文献
1